1. Zerem E, Kurtcehajic A, Kunosic S, Zerem Malkocevic D, ZeremO. Current trends in acute pancreatitis: Diagnostic and therapeuticchallenges. World J Gastroenterol. 2023;29(18):2747-2763. doi: 10.3748/wjg.v29.i18.2747.
2. Kiyak M, Tanoglu A. Comparison of the Efficacy of Balthazar Scoreand C-Reactive Protein-Albumin Ratio for Determination of AcutePancreatitis Severity. Curr Health Sci J. 2022;48(1):81-87. doi: 10.12865/CHSJ.48.01.12.
3. Tanoglu A, Yazgan Y, Kaplan M, et al. Trimetazidine significantlyreduces cerulein-induced pancreatic apoptosis. Clin Res HepatolGastroenterol. 2015;39(1):145-150. doi:10.1016/j.clinre.2014.06.003.
4. Kaplan M, Yazgan Y, Tanoglu A, et al. Effectiveness of interleukin-1receptor antagonist (Anakinra) on cerulein-induced experimentalacute pancreatitis in rats. Scand J Gastroenterol. 2014;49(9):1124-1130.doi: 10.3109/00365521.2014.926983.
5. Güney BÇ, Tanoğlu A, Yeniçeri M, Çırak Z, Sade AG, Taştan YÖ,Serindağ Z, Kaplan M. Favorable efficacy of adalimumab treatment inexperimental acute pancreatitis model. Turk J Med Sci. 2022 ;52(6):1821-1828. doi: 10.55730/1300-0144.5528.
6. Kaplan M, Tanoğlu A, Çakır Güney B, et al. Golimumab amelioratespancreatic inflammatory response in the cerulein-induced acutepancreatitis in Rats. Turk J Gastroenterol. 2022;33(11):918-924. doi:10.5152/tjg.2022.21456.
7. Tanoğlu EG, Tanoğlu A, Meriçöz Aydın MÇ, Esen MF. Melatonin hasfavorable preventive effects on experimental chronic pancreatitis ratmodel. Turk J Med Sci. 2021;51(5):2734-2740. doi: 10.3906/sag-2103-134.
8. Yildirim M, Kaplan M, Duzenli T, et al. Pentoxifylline has favorablepreventive effects on experimental chronic pancreatitis model. Scand JGastroenterol. 2020 ;55(2):236-241. doi: 10.1080/00365521.2020.1712471.
9. Hançerli Y, Kaplan M, Tanoğlu A, et al. Efficacy of tocilizumabtreatment in cerulein-induced experimental acute pancreatitismodel in rats. Turk J Gastroenterol. 201728(6):485-491. doi: 10.5152/tjg.2017.16738.
10. Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy.Drugs. 2011;71(4):489-514. doi: 10.2165/11204490-000000000-00000.
11. Azar NJ, Aune P. Acute pancreatitis and elevated liver transaminasesafter rapid titration of oral levetiracetam. J Clin Neurosci. 2014;21(6):1053-1054. doi: 10.1016/j.jocn.2013.08.016.
12. Tanoglu A, Cagiltay E, Beyazit Y. Spiramycin-associated AcutePancreatitis: Cause or Coincidence? Med Sci. 2015;4(2):2352-2355.
13. Tanoğlu A, Çağıltay E. Tigecycline induced acute pancreatitis: Suspicionis the first step in diagnosis. Anatolian Curr Med. 2021;3(3):262-3.doi:10.38053/acmj.955678.
14. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating theprobability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.